Skip to main content
Log in

L-menthol exhibits antidepressive-like effects mediated by the modification of 5-HTergic, GABAergic and DAergic systems

  • Research Article
  • Published:
Cognitive Neurodynamics Aims and scope Submit manuscript

Abstract

Major depression disorder, also known as depression, with a significant and persistent low mood as the main clinical features, is the main type of mood disorders. L-menthol (LM), the main active ingredient of mint, has been considered as safe and healthy natural ingredient by the Food and Drug Administration in the USA. In this study, LM (40 mg/kg, i.g.) produced antidepressant-like effect in the forced swimming test (FST) in mice. The sub-effective dose (5 mg/kg, i.g.) of LM combined with the sub-effective dose of fluoxetine (5 mg/kg, i.p.) or reboxetine (2.5 mg/kg, i.p.) could significantly shorten the immobility time in the FST. Pretreatment with ondansetron (a highly selective 5-HT3 receptor antagonist, 8 mg/kg, i.p.), bicuculline [a competitive γ-aminobutyric acid (GABA) antagonist, 4 mg/kg, i.p.] and haloperidol (a non-selective D2 receptor antagonist, 0.2 mg/kg, i.p.) significantly reversed the antidepressant-like effect of LM (40 mg/kg, i.g.). In contrast, prazosin (a α1-adrenoceptor antagonist, 1 mg/kg, i.p.) and N-methyl-d-aspartic acid (an agonist at the glutamate site, 75 mg/kg, i.p.) did not eliminate the antidepressant-like effect of LM. All of these above indicated that LM is able to induce an antidepressant-like effect mediated by the modification of 5-HTergic, GABAergic and DAergic systems in the FST. LM might be used as combination therapy in depressed patients and is a potential antidepressant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Amiri S, Amini-Khoei H, Mohammadi-Asl A, Alijanpour S, Haj-Mirzaian A, Rahimi-Balaei M, Razmi A, Olson CO, Rastegar M, Mehdizadeh M, Zarrindast MR (2016) Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse. Physiol Behav 163:107–114

    Article  CAS  PubMed  Google Scholar 

  • Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358(1):55–68

    Article  CAS  PubMed  Google Scholar 

  • Bian X, Liu X, Liu J, Zhao Y, Li H, Cai E, Li P, Gao Y (2018) Study on antidepressant activity of chiisanoside in mice. Int Immunopharmacol 57:33–42

    Article  CAS  PubMed  Google Scholar 

  • Borsini F, Mancinelli A, D’Aranno V, Evangelista S, Meli A (1988) On the role of endogenous GABA in the forced swimming test in rats. Pharmacol Biochem Behav 29(2):275–279

    Article  CAS  PubMed  Google Scholar 

  • Brocco M, Dekeyne A, Papp M, Millan MJ (2006) Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Behav Pharmacol 17(7):559–572

    Article  CAS  PubMed  Google Scholar 

  • Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64(3):327–337

    Article  CAS  PubMed  Google Scholar 

  • Ellrich J (2005) Dopamine D2-like receptor activation antagonizes long-term depression of orofacial sensorimotor processing in anesthetized mice. Brain Res 1035(1):94–99

    Article  CAS  PubMed  Google Scholar 

  • Frisardi V, Panza F, Farooqui AA (2011) Late-life depression and Alzheimer’s disease: the glutamatergic system inside of this mirror relationship. Brain Res Rev 67(1–2):344–355

    Article  CAS  PubMed  Google Scholar 

  • Frye MA, Grunze H, Suppes T, McElroy SL, Keck PE Jr, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM (2007) A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 164(8):1242–1249

    Article  PubMed  Google Scholar 

  • Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D (2014) The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Transl Psychiatry 4(7):e411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gershon AA, Vishne T, Grunhaus L (2007) Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 61(2):145–153

    Article  CAS  PubMed  Google Scholar 

  • Gronli J, Fiske E, Murison R, Bjorvatn B, Sorensen E, Ursin R, Portas CM (2007) Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 181(1):42–51

    Article  CAS  PubMed  Google Scholar 

  • Guo D, Gan J, Tan T, Tian X, Wang G, Ng KT (2018) Neonatal exposure of ketamine inhibited the induction of hippocampal long-term potentiation without impairing the spatial memory of adult rats. Cogn Neurodyn 12(4):377–383

    Article  PubMed  PubMed Central  Google Scholar 

  • Hao L, Yang Z, Gong P, Lei J (2018) Maintenance of postsynaptic neuronal excitability by a positive feedback loop of postsynaptic BDNF expression. Cogn Neurodyn 12(4):403–416

    Article  PubMed  PubMed Central  Google Scholar 

  • Henderson BJ, Wall TR, Henley BM, Kim CH, McKinney S, Lester HA (2017) Menthol enhances nicotine reward-related behavior by potentiating nicotine-induced changes in nAChR function, nAChR upregulation, and DA neuron excitability. Neuropsychopharmacology 42(12):2285–2291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hiraoka K, Motomura K, Yanagida S, Ohashi A, Ishisaka-Furuno N, Kanba S (2017) Pattern of c-Fos expression induced by tail suspension test in the mouse brain. Heliyon 3(6):e00316

    Article  PubMed  PubMed Central  Google Scholar 

  • Ikeda M, Kitajima T, Iwata N, Ozaki N (2002) Molecular genetics of mood disorders. Nihon Shinkei Seishin Yakurigaku Zasshi 22(5):137–143

    CAS  PubMed  Google Scholar 

  • Kamei J, Saitoh A, Iwamoto Y, Funada M, Suzuki T, Misawa M, Nagase H, Kasuya Y (1994) Effects of diabetes on spontaneous locomotor activity in mice. Neurosci Lett 178(1):69–72

    Article  CAS  PubMed  Google Scholar 

  • Krzywkowski K, Davies PA, Feinberg-Zadek PL, Brauner-Osborne H, Jensen AA (2008) High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor. Proc Natl Acad Sci USA 105(2):722–727

    Article  PubMed  Google Scholar 

  • Lepine JP, Briley M (2011) The increasing burden of depression. Neuropsychiatr Dis Treat 7(Suppl 1):3–7

    PubMed  PubMed Central  Google Scholar 

  • Lin R, Tian J, Huang G, Li T, Li F (2002) Analysis of menthol in three traditional Chinese medicinal herbs and their compound formulation by GC-MS. Biomed Chromatogr 16(3):229–233

    Article  CAS  PubMed  Google Scholar 

  • Lin M, Li H, Zhao Y, Cai E, Zhu H, Gao Y, Liu S, Yang H, Zhang L, Tang G, Wang R (2017) Ergosteryl 2-naphthoate, an ergosterol derivative, exhibits antidepressant effects mediated by the modification of GABAergic and glutamatergic systems. Molecules 22(4):565

    Article  CAS  PubMed Central  Google Scholar 

  • Machado-Vieira R, Manji HK, Zarate CA (2009) The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist 15(5):525–539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marecos C, Ng J, Kurian MA (2014) What is new for monoamine neurotransmitter disorders? J Inherit Metab Dis 37(4):619

    Article  CAS  PubMed  Google Scholar 

  • Mayberg HS (2003) Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 13(4):805–815

    Article  PubMed  Google Scholar 

  • Mezadri TJ, Batista GM, Portes AC, Marino-Neto J, Lino-de-Oliveira C (2011) Repeated rat-forced swim test: reducing the number of animals to evaluate gradual effects of antidepressants. J Neurosci Methods 195(2):200–205

    Article  CAS  PubMed  Google Scholar 

  • Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945):766–781

    Article  PubMed  PubMed Central  Google Scholar 

  • Palucha-Poniewiera A, Podkowa K, Lenda T, Pilc A (2017) The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 79(Pt B):155–161

    Article  CAS  PubMed  Google Scholar 

  • Pesarico AP, Sampaio TB, Stangherlin EC, Mantovani AC, Zeni G, Nogueira CW (2014) The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems. Prog Neuropsychopharmacol Biol Psychiatry 54(15):179–186

    Article  CAS  PubMed  Google Scholar 

  • Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327–336

    CAS  PubMed  Google Scholar 

  • Rajkowska G (2003) Depression: what we can learn from postmortem studies. Neuroscientist 9(4):273–284

    Article  PubMed  Google Scholar 

  • Salat K, Kulig K, Gajda J, Wieckowski K, Filipek B, Malawska B (2013) Evaluation of anxiolytic-like, anticonvulsant, antidepressant-like and antinociceptive properties of new 2-substituted 4-hydroxybutanamides with affinity for GABA transporters in mice. Pharmacol Biochem Behav 110:145–153

    Article  CAS  PubMed  Google Scholar 

  • Sherman AD, Petty F (1980) Neurochemical basis of the action of antidepressants on learned helplessness. Behav Neural Biol 30(2):119–134

    Article  CAS  PubMed  Google Scholar 

  • Sultana J, Italiano D, Spina E, Cricelli C, Lapi F, Pecchioli S, Gambassi G, Trifiro G (2014) Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study. Eur J Clin Pharmacol 70(4):469–478

    Article  PubMed  Google Scholar 

  • Tardito D, Molteni R, Popoli M, Racagni G (2012) Synergistic mechanisms involved in the antidepressant effects of agomelatine. Eur Neuropsychopharmacol 22(Suppl 3):S482–S486

    Article  CAS  PubMed  Google Scholar 

  • Thompson AJ, Lummis SC (2005) 5-HT3 receptors. Curr Pharm Des 12(28):3615–3630

    Article  Google Scholar 

  • Tóth K, Höfner G, Wanner KT (2018) Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors. Bioorg Med Chem 26(12):3668–3687

    Article  CAS  PubMed  Google Scholar 

  • Tozzi A, Peters JF, Cankaya MN (2018) The informational entropy endowed in cortical oscillations. Cogn Neurodyn 12(5):501–507

    Article  PubMed  Google Scholar 

  • Walker AJ, Burnett SA, Hasebe K, McGillivray JA, Gray LJ, McGee SL, Walder K, Berk M, Tye SJ (2013) Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels. Behav Brain Res 242:76–83

    Article  CAS  PubMed  Google Scholar 

  • Walstab J, Rappold G, Niesler B (2010) 5-HT 3 receptors: role in disease and target of drugs ☆. Pharmacol Ther 128(1):146–169

    Article  CAS  PubMed  Google Scholar 

  • Yamagata H, Uchida S, Matsuo K, Harada K, Kobayashi A, Nakashima M, Higuchi F, Watanuki T, Matsubara T, Watanabe Y (2018) Altered plasma protein glycosylation in a mouse model of depression and in patients with major depression. J Affect Disord 233:79–85

    Article  CAS  PubMed  Google Scholar 

  • Zhang LM, Zhao N, Guo WZ, Jin ZL, Qiu ZK, Chen HX, Xue R, Zhang YZ, Yang RF, Li YF (2014) Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa). Neuropharmacology 81:116–125

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are grateful for the National key R&D program (Grant No. 2016YFC0500303), the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303111), and Jilin Province Science and Technology Development Program (Grant Nos. 20160307005YY, 20150307012YY).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yan Zhao or Yugang Gao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Jiang, Y., Cai, E. et al. L-menthol exhibits antidepressive-like effects mediated by the modification of 5-HTergic, GABAergic and DAergic systems. Cogn Neurodyn 13, 191–200 (2019). https://doi.org/10.1007/s11571-018-9513-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11571-018-9513-1

Keywords

Navigation